OBJECTIVE: Olfactory dysfunction is the most common pre-motor symptom in Parkinson's disease (PD), and smoking is known to be associated with lower risk of PD. This study tested the hypothesis that smoking is associated with better olfaction in PD. METHODS: Smoking history was obtained from 76 PD subjects (22 with a history of smoking [smokers], 54 who never smoked [nonsmokers]), and 70 controls (17 smokers, 53 nonsmokers). Olfaction was assessed using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). The olfactory scores between groups and subgroups were compared using analysis of covariance with adjustment for age, gender, and monoamine oxidase B (MAO-B) inhibitor usage. RESULTS: Overall the olfactory score was lower in PD compared with controls (olfactory scores: 21.5 vs. 33.5, P < 0.0001). Among controls, there was no significant difference in olfaction between smokers and nonsmokers (olfactory scores, 33.2 vs. 34.2; P = 0.95). Among PD subjects, however, smokers scored significantly better regarding olfaction compared with nonsmokers (olfactory scores: 24.4 vs. 19.9, P = 0.02). CONCLUSIONS: These data suggest that a history of smoking is associated with better olfaction among PD patients. The finding may be related to why smoking may be protective against PD. Further studies are needed to confirm this finding and investigate the underlying mechanisms.
OBJECTIVE:Olfactory dysfunction is the most common pre-motor symptom in Parkinson's disease (PD), and smoking is known to be associated with lower risk of PD. This study tested the hypothesis that smoking is associated with better olfaction in PD. METHODS: Smoking history was obtained from 76 PD subjects (22 with a history of smoking [smokers], 54 who never smoked [nonsmokers]), and 70 controls (17 smokers, 53 nonsmokers). Olfaction was assessed using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). The olfactory scores between groups and subgroups were compared using analysis of covariance with adjustment for age, gender, and monoamine oxidase B (MAO-B) inhibitor usage. RESULTS: Overall the olfactory score was lower in PD compared with controls (olfactory scores: 21.5 vs. 33.5, P < 0.0001). Among controls, there was no significant difference in olfaction between smokers and nonsmokers (olfactory scores, 33.2 vs. 34.2; P = 0.95). Among PD subjects, however, smokers scored significantly better regarding olfaction compared with nonsmokers (olfactory scores: 24.4 vs. 19.9, P = 0.02). CONCLUSIONS: These data suggest that a history of smoking is associated with better olfaction among PDpatients. The finding may be related to why smoking may be protective against PD. Further studies are needed to confirm this finding and investigate the underlying mechanisms.
Authors: G G Brown; A A Rahill; J M Gorell; C McDonald; S J Brown; M Sillanpaa; C Shults Journal: J Geriatr Psychiatry Neurol Date: 1999 Impact factor: 2.680
Authors: Alexis Elbaz; James H Bower; Brett J Peterson; Demetrius M Maraganore; Shannon K McDonnell; J Eric Ahlskog; Daniel J Schaid; Walter A Rocca Journal: Arch Neurol Date: 2003-01
Authors: J Vent; A M Robinson; M J Gentry-Nielsen; D B Conley; R Hallworth; D A Leopold; R C Kern Journal: Laryngoscope Date: 2004-08 Impact factor: 3.325
Authors: James D Sharer; Fidias E Leon-Sarmiento; James F Morley; Daniel Weintraub; Richard L Doty Journal: Mov Disord Date: 2014-12-27 Impact factor: 10.338
Authors: Lijun Zhang; Xue Wang; Ming Wang; Nick W Sterling; Guangwei Du; Mechelle M Lewis; Tao Yao; Richard B Mailman; Runze Li; Xuemei Huang Journal: Front Neurol Date: 2017-09-27 Impact factor: 4.003
Authors: Heike Rebholz; Ralf J Braun; Dennis Ladage; Wolfgang Knoll; Christoph Kleber; Achim W Hassel Journal: Front Neurol Date: 2020-10-26 Impact factor: 4.003